hat
Kòm jenetik rechèch ap pwogrese nan 20yèm syèk la, syantis yo te itilize konesans sa yo devlope nouvo tretman. pwogrè Dènye te enkli vize terapi. Sa yo gen plis espesifik nan aksyon yo kont timè paske yo aji sou objektif molekilè ki asosye ak selil kansè patikilye, Lè nou konsidere ke pi chimyoterapi estanda aji sou tout selil rapidman divize, se pou yo nòmal oswa kansè.
eng
As genomic research progressed in the 20th century, scientists have used that knowledge to develop new treatments. Recent advances have included targeted therapies. These are more specific in their action against tumours because they act on molecular targets associated with particular cancer cells, whereas most standard chemotherapies act on all rapidly dividing cells, be they normal or cancerous.